CEO, Board Member, Chief Accounting Officer
2024-08-09–present
Board Member
Beam Therapeutics Inc. (BEAM)Head of Investor Relations
GrowGeneration Corp. (GRWG)Chief Accounting Officer
Beam Therapeutics Inc. (BEAM)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
John Evans is recorded as CEO, Board Member and Chief Accounting Officer at Beam Therapeutics Inc. (BEAM) and Head of Investor Relations at GrowGeneration Corp. (GRWG). The proxy statement of Beam Therapeutics Inc. reports total compensation of $5,818,525 for John Evans in fiscal 2025, including a base salary of $755,000. Disclosed compensation is on record for 7 fiscal years. John Evans has spoken on 3 earnings calls and 1 other investor event across 2 companies, most recently for Beam Therapeutics Inc. on September 8, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2024-08-09–present
Start not stated–present
Start not stated–present
Recorded roles and call appearances connecting this person to public companies.
CEO, Board Member, Chief Accounting Officer
2024-08-09–present
GRWG
Head of Investor Relations
Other people whose current roles at this company are on record from its filings.
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Beam Therapeutics Inc. (BEAM) | CEO | $755,000 | $5,818,525 |
| 2024 | Beam Therapeutics Inc. (BEAM) | CEO | $715,750 | $6,409,631 |
| 2023 | Beam Therapeutics Inc. (BEAM) | CEO | $685,000 | $6,280,099 |
| 2022 | Beam Therapeutics Inc. (BEAM) | CEO | $650,000 | $9,496,745 |
| 2021 | Beam Therapeutics Inc. (BEAM) | CEO | $590,105 | $13,911,975 |
| 2020 | Beam Therapeutics Inc. (BEAM) | CEO | $529,271 | $906,768 |
| 2019 | Beam Therapeutics Inc. (BEAM) | CEO | $472,500 | $2,209,800 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.